Press release Ecully, 5 April 2017
Signature of a distribution agreement in Australia
1st Mont-Blanc implants
Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine), announces the signature of a contract with an Australian distributor for the sale of its implants and instruments in Oceania.
The distribution agreement follows the approval of the Group's flagship lines and reinforces Spineway's international coverage.
The distributor, based in Sydney, specializes in orthopedics and is extremely experienced with the spine. It will sell Spineway's Mont-Blanc, TwinPeaks, Kili, Ayers Rock and Blue Mountain lines. Its salesforce and distribution network will allow the Group to cover Sydney and Australia's other major cities.
The first surgeries using Mont-Blanc implants have already taken place and were very successful.
Spineway thus establishes its know-how in overseas exports and should see its sales increase steadily in this new geographic area.
SPINEWAY IS ELIGIBLE FOR THE PEA-PME (EQUITY SAVINGS PLAN FOR SMES)
Find out all about Spineway at www.spineway.com
Next communication:
2016 Annual Results - 26 April 2017, after market closes
Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of over 50 independent distributors and 90% of its turnover comes from exports.
Spineway, which is eligible for investment through FCPIs (French unit trusts specializing in innovation), received the OSEO Excellence award as well as the Deloitte Fast 50 award in 2011. Rhône Alpes INPI Patent Innovation Award (2013) - Talent INPI award (2015).
ISIN code: FR0011398874 - ALSPW
Contacts:
| Investor Relations David Siegrist - Finance Director Tel: +33 (0)4 72 77 01 52 finance.dsg@spineway.com | Financial Communication Jérôme Gacoin / Solène Kennis Tel: +33 (0)1 75 77 54 68 skennis@aelium.fr |
